On 7 December 2022, the Commission tabled two proposals to modify the current framework that applies to EU central clearing counterparties (CCPs) and… Excessive and concentrated exposures to third-country central counterparties
This note offers links to recent reports and commentaries from some major international think tanks and research institutes on the debates relating … Industrial policy, State aid and clean tech
A European Hub for imaging on cancers and the use of Artificial Intelligence is borning. Fully operational by 2026. 23 January 2023 Today, at an event in Brussels, the Commission is launching the European Cancer Imaging Initiative to support healthcare providers, research institutes and innovators in making the best use of innovative data-driven
The Commission published the transition pathway, co-created with relevant parties in the social economy sector, to help social economy entities and small local businesses become greener and more digital. Brussels, 10 January 2023 The EU Commission puts forward a set of 30 actions in 14 different areas. For instance, the transition pathway proposes actions to help social
The EU has decided that all Europeans of working and studying age must have a personal endowment allocated by their state in order to have permanent access to learning and training. Why? Because the EU’s ambitions in digital, health, energy and environment require specific skills that are lacking today and risk wrecking Brussels’ plans. Brussels,
The fight against the COVID-19 pandemic has highlighted the need and urgency for Europe to have rapid reaction mechanisms in place to protect its citizens. The 2019 coronavirus has highlighted the discrepancies in assessments between the 27 countries, both of the threat to health and of the measures to be taken to help citizens.
The EU has taken a new approach to cancer screening to improve early detection across the EU. This is another important European step in the fight against cancer. In fact, many of the new recommendations are already a reality in many European countries. The aim is to extend best practices in all 27 EU countries.
Hemgenix (etranacogene dezaparvovec) is now available on the European market for the treatment of severe and moderately severe haemophilia B in adults without factor IX inhibitors (autoantibodies produced by the immune system that make drugs against factor IX less effective). The recommendation for the granting of marketing authorization in EU countries is from the
“Digital transformation is one of the six policy areas around which the RRF is built. Given its high priority for the EU, each national plan has to allocate at least 20 % of its resources to digital targets. The funds are meant to complement financing from the EU budget and national budgets and help
Brussels, 20 December 2022 Gas price cap at €180/MWh. EU energy ministers reached a political agreement on a Council Regulation that sets a market correction mechanism to protect citizens and the economy against excessively high prices. The Regulation aims to limit episodes of excessive gas prices in the EU that do not reflect world